MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study

    C. Cerquera-Cleves, G. Pinilla-Monsalve, M. Blais, M. Cressati, C. Normandeau, C. Degroot, I. Kathol, S. Bogard, A. Bendas, R. Camicioli, Z. Gan-Or, DA. Grimes, K. Schoffer, LV. Kalia, PA. Macdonald, MJ. Mckeown, D. Martino, J. Miyasaki, M. Schlossmacher, AJ. Stoessl, A. Strafella, E. Fon, O. Monchi, N. Dupré, F. Cicchetti (Québec, Canada)

    Objective: To evaluate the clinical outcomes associated with pesticide exposure in Parkinson’s disease (PD) participants in the Canadian Open Parkinson Network (COPN)(1). Background: Pesticide exposure…
  • 2025 International Congress

    Age-related Trends in Amyloid Positivity in Parkinson’s Disease without Dementia

    K. Hatano, M. Kameyama, M. Kurihara, K. Ohse, R. Goto, R. Ihara, M. Higashihara, R. Sengoku, Y. Nishina, K. Kanemaru, Y. Saito, S. Murayama, A. Iwata (Tokyo, Japan)

    Objective: To identify the prevalence of amyloid positivity in patients with Parkinson’s disease (PD) without dementia in their eighties using CSF amyloid-beta 42 levels and…
  • 2025 International Congress

    Food-Related Predictors of Parkinson Progression

    L. Mischley, J. Farahnik, M. Murawska (Kenmore, USA)

    Objective: The goal of this study was to describe the current food-related behaviors associated with subsequent Parkinson disease (PD) symptom severity. Background: The Modifiable Variables…
  • 2025 International Congress

    The efficacy and safety of continuous subcutaneous infusion therapy with foslevodopa/foscarbidopa

    M. Shiraishi, N. Takao, Y. Nakano, Y. Yamano (Kawasaki City, Japan)

    Objective: To clarify the actual status of CSCI therapy, cases in which CSCI therapy was started at our hospital were investigated. Background: Continuous subcutaneous infusion…
  • 2025 International Congress

    A personalized gait signature assay in Parkinson’s disease

    H. Babcock, J. Stephen, V. Vanderhorst (Boston, USA)

    Objective: To establish a personalized gait signature assay to inform on progression, phenotype and effects of intervention of gait abnormalities in PD. Background: Gait signatures…
  • 2025 International Congress

    PREDIGT 2.0: A Self-Administered, Two-Step Screening Tool to Identify Individuals with Parkinson’s Disease

    J. Li, K. Grimes, J. Saade, N. Mauri, J. Tomlinson, A. Frank, D. Manuel, B. Mollenhauer, M. Schlossmacher (Ottawa, Canada)

    Objective: To pilot the 2-step PREDIGT Score model for feasibility and improve it by simplifying both steps. Background: We previously demonstrated that the original PREDIGT…
  • 2025 International Congress

    Force Estimation as a Method to Assess Proprioception in Parkinson’s Disease Patients

    M. Wilken, G. Bianchi, M. Martínez Sucre, C. Cruz Molina, G. Noel, D. Andres, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the validity of force estimation as a method for assessing proprioception, and to determine if proprioception is impaired in Parkinson's disease (PD)…
  • 2025 International Congress

    A Study of Delayed Specialist Consultation in Parkinson’s Disease Patients in Uzbekistan

    L. Kenjaeva, B. Mukhammedaminov, N. Aripova, Y. Nishonova, G. Kendjaeva (Tashkent, Uzbekistan)

    Objective: Parkinson’s disease (PD) is a progressive neurodegenerative disorder where early diagnosis is crucial for preserving motor function and improving quality of life. However, in…
  • 2025 International Congress

    Impact of Innovative Physiotherapy Interventions on Motor Function and Quality of Life in Patients with Parkinson’s Disease and Movement Disorders

    E. Nakanwagi, G. Wangolo (KAMPALA, Uganda)

    Objective: 1. Assess the extent to which innovative physiotherapy interventions improve motor function, as measured by the Unified Parkinson’s Disease Rating Scale (UPDRS).2. Determine the…
  • 2025 International Congress

    Association Between Depression and Sleep Disorders in Parkinson’s Disease

    J. Jiang, W. Wu, M. Mao (Suzhou, China)

    Objective: To investigate the clinical characteristics of depression in Parkinson’s disease (PD) and its correlation with sleep disorders. Background: PD is the second most common…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley